biomarker

Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate a 73.3% overall response rate and 60% complete response rate from 15 heavily pre-treated…

New York, USA, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Vocal Biomarkers Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Vocal Biomarkers…

Fosgonimeton treatment-related reductions in biomarkers of neurodegeneration (NfL) and neuroinflammation (GFAP) significantly correlated with improvements in clinical outcomes as assessed…

Researchers at Karolinska Institutet in Sweden have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood. Moreover, high IL-26 levels…

A definitive diagnosis of Alzheimer's disease (AD) was once only possible after someone had died, but recent biomarker studies have led to the development of imaging and spinal fluid tests…

Remnants of ancient viruses in the human genome are active in healthy tissues as well as diseased ones, limiting their utility as disease biomarkers, according to a study by Aidan Burn at…

The mitochondria is a key energy-producing component of the human cell that plays an important role in cancer cell metabolism. In a research paper published in PLOS ONE, Dario C. Altieri,…

High tumor mutational burden -- the number of mutations found inside cancer cells -- may not generalize as an accurate biomarker across diverse cancer patient populations, researchers report…

It may soon be possible to identify Group 4 medulloblastomas -- the most common malignant brain tumor in children -- from more aggressive Group 3 tumors. Research based on a little-explored…

Data support further evaluation of PVR, CD226, and TIGIT as potential biomarkers of enrichment for etigilimab plus anti-PD1 therapy Continued clinical benefit observed with the combination…